Several studies indicate that the higher plasma cfDNA concentrations in Pca patients are correlated to a positive biopsy, high Gleason score, PSA recurrence, and shorter BCR-free survival [133,134]. This evidence concerns the gene BCR and posterior cortical atrophy.